Document is current

Any future updates will be listed below

Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients

Crossref DOI link: https://doi.org/10.1186/s12885-016-2578-5

Published Online: 2016-07-25

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark